Fulminant type 1 diabetes in Korea: high prevalence ... - Springer Link

2 downloads 0 Views 99KB Size Report
Aug 28, 2007 - urine); and have elevated serum pancreatic enzyme levels. In Japan, the ... stimulated C-peptides, arterial blood pH, and anion gap at.
Diabetologia (2007) 50:2276–2279 DOI 10.1007/s00125-007-0812-z

SHORT COMMUNICATION

Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes Y. M. Cho & J. T. Kim & K. S. Ko & B. K. Koo & S. W. Yang & M. H. Park & H. K. Lee & K. S. Park

Received: 9 July 2007 / Accepted: 3 August 2007 / Published online: 28 August 2007 # Springer-Verlag 2007

Abstract Aims/hypothesis The aim of this study was to investigate the prevalence of fulminant type 1 diabetes and the clinical characteristics of the disease among newly diagnosed Korean patients. Methods Using data retrieved from the Seoul National University Hospital database, we identified all patients newly diagnosed with type 1 diabetes from 1 January 1999 to 31 July 2006. Information on clinical manifestations and laboratory data, including the presence of islet autoantibodies detected at diagnosis, were obtained by reviewing medical records. Results We identified 99 patients newly diagnosed with type 1 diabetes. Seven patients (7.1%) fulfilled the criteria for fulminant type 1 diabetes. Among the patients aged ≥18 years at onset, 30.4% had fulminant type 1 diabetes. Y. M. Cho and J. T. Kim contributed equally to this work. Y. M. Cho : J. T. Kim : B. K. Koo : H. K. Lee : K. S. Park (*) Department of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea e-mail: [email protected] K. S. Ko Department of Internal Medicine, Inje University College of Medicine, Seoul, South Korea S. W. Yang Department of Paediatrics, Seoul National University College of Medicine, Seoul, South Korea M. H. Park Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea

Patients with this diabetes subtype tested negative for islet autoantibodies, had a higher age of onset (median 28 vs 10 years, p